Breaking News, Promotions & Moves

Stuart Therapeutics Taps Dr. Lukas Scheibler as Chief Science & Technology Officer

Scheibler is an R&D professional with in-depth experience in drug development.

Author Image

By: Charlie Sternberg

Associate Editor

Stuart Therapeutics, a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, has added Lukas Scheibler, PhD as its Chief Science and Technology Officer. “The advancement of our pipeline of novel collagen mimetic peptide therapeutics has increased the need for us to augment our capabilities. We are excited to have Lukas join the Stuart Therapeutics team as our Chief Science and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters